Antibody treatments are safe and effective for transplant patients with mild to moderate COVID-19, a new study shows. Monoclonal antibodies help prevent the SARS-CoV-2 virus from attaching to cells, which helps block the spread of infection. The findings are important, researchers said, because transplant patients with COVID are more likely to be severely ill or… read on > read on >







